Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Algernon Pharmaceuticals submits pre-investigational new drug meeting request with US FDA for its DMT stroke research program

% of readers think this story is Fact. Add your two cents.


Algernon Pharmaceuticals Inc (CSE:AGN) (OTCQB:AGNPF) (FRA:AGW) has started formal communication with the US regulator, the Food and Drug Administration (FDA), over its previously announced stroke clinical research program.

The company said it had now filed a pre-IND (Investigational New Drug) meeting request with the agency about its investigation of psychedelic compound DMT as a treatment for stroke.

READ: Algernon Pharmaceuticals updates on timing of topline results for Ifenprodil trial

Specifically, it is asking for direction regarding the use of DMT as an adjunctive treatment with constraint-induced movement therapy (CIMT) to treat upper-limb dysfunction in stroke patients.

Another pre-IND meeting request for its use to treat acute stroke will be filed once additional preclinical work is completed, added Algernon.

CIMT is a therapy, which involves intensive training of the weaker limb while restricting the stronger limb, and has shown it can enhance recovery in patients post-stroke.

CIMT is also used in the treatment of other movement disorders, including traumatic brain injury, multiple sclerosis, and Parkinson’s disease.

Unlike other companies researching such drugs, Algernon has said it will focus on a sub-hallucinogenic, or microdose of DMT given via continuous intravenous administration -  the aim being the patient will not have a psychedelic experience. 

The company has noted that this approach may also allow for a quicker pathway to regulatory approval, including a Breakthrough Therapy designation from the US FDA.

On March 1 this year, Algernon reported that a Phase 1 study on the psychedelic compound DMT to treat stroke will be carried out by London-based contract research organization (CRO) Hammersmith Medicines Research (HMR).

The Phase 1 study is anticipated to begin as soon as the company has cGMP drug product from its recently appointed manufacturer Dalton Pharma and will evaluate the safety, tolerability and pharmacokinetics of the proposed sub-psychedelic DMT dosages in healthy participants with no prior history of psychedelic exposure. It will provide essential data on the proposed dosing regimen, and also inform the design of the planned Phase 2 trials.

Algernon also recently hired Charles River Laboratories to conduct its preclinical studies of DMT for the stroke research program.

Contact the author at [email protected]

Story by ProactiveInvestors



Source: http://www.proactiveinvestors.com/companies/news/944127/algernon-pharmaceuticals-submits-pre-investigational-new-drug-meeting-request-with-us-fda-for-its-dmt-stroke-research-program-944127.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!


Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST


Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen! 
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover -  Reduces Smart Meter radiation by 96%!  (See Video)

Immusist Beverage Concentrate - Proprietary blend, formulated to reduce inflammation while hydrating and oxygenating the cells.

Report abuse
Loading...

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.